Cancer-Associated Thrombosis: From Biomarkers to Diagnostic and Therapeutic Strategies to Optimize Treatment
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Cancer Biology and Oncology".
Deadline for manuscript submissions: 31 October 2025 | Viewed by 50
Special Issue Editors
Interests: pulmonary embolism; lung cancer; extracellular vesicles tissue factor; anticoagulant; chest imaging
Interests: coagulation; thrombosis; cardiology; pulmonary embolism; phlebology
Special Issue Information
Dear Colleagues,
This Special Issue, entitled “Cancer-Associated Thrombosis: From Biomarkers to Diagnostic and Therapeutic Strategies to Optimize Treatment”, aims to focus on the role of emerging biomarkers and the pathophysiological mechanisms, clinical manifestations, and novel diagnostic and therapeutic approaches of thromboembolism in cancer patients.
Cancer-related thromboembolism (CAT) is an epidemiologically growing disease that has a major impact on patient morbidity and mortality, as well as on economic and human resources. Interest in this issue is strong, and we need to improve our knowledge about pathophysiological mechanisms, the identification of disease markers with clinical implications, and the optimization of diagnostic and therapeutic pathways in order to improve the management of each individual patient. There are a lot of gaps in the literature, so innovation needs to be continued in this field.
This Special Issue welcomes the submission of both clinical and basic research in the form of original articles and reviews regarding pathophysiology and the molecular mechanisms of cancer-related thrombosis (pulmonary embolism, venous thrombosis, etc.), the peculiarities associated with the individual tumor site (for example, thrombotic or hemorrhagic risk), and traditional and innovative diagnostic and therapeutic approaches to improve basic knowledge and clinical management.
Dr. Roberta Pancani
Dr. Gualtiero Palareti
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cancer-associated thrombosis
- venous thrombosis
- biomarkers
- pulmonary embolism
- precision medicine
- diagnostic optimization
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
